NCT07242339

Brief Summary

This prospective, randomized, controlled, and multicenter clinical study aims to compare the postoperative analgesic efficacy of two regional anesthesia techniques commonly used in knee arthroscopy: adductor canal block (ACB) and combined adductor canal block plus biceps femoris short head (ACB+BiFeS) block. The study will evaluate postoperative pain control, opioid consumption, adverse effects, hospital stay, and patient satisfaction. Findings will help determine the most effective and safe method for postoperative analgesia in knee arthroscopy patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

November 20, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2026

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

January 20, 2026

Status Verified

November 1, 2025

Enrollment Period

4 months

First QC Date

November 17, 2025

Last Update Submit

January 16, 2026

Conditions

Keywords

regional anesthesia

Outcome Measures

Primary Outcomes (1)

  • Total Opioid Consumption (Tramadol, mg)

    The total dose of tramadol administered via intravenous patient-controlled analgesia (PCA) device within the first 24 hours postoperatively will be recorded in milligrams.

    24 hours

Secondary Outcomes (6)

  • Postoperative Pain with Movement and at rest (NRS)

    At 0, 6, 12, and 24 hours after surgery

  • Rescue Analgesia Requirement

    Within the first 24 hours postoperatively

  • Incidence of Nausea and Vomiting

    Within the first 24 hours postoperatively

  • Quality of Recovery (QOR-15 score)

    At 24 hours after surgery

  • Dermatomal Spread of Block

    2nd hour postoperatively

  • +1 more secondary outcomes

Study Arms (2)

Adductor Canal Block (ACB)

ACTIVE COMPARATOR

Participants will undergo ultrasound-guided adductor canal block at the end of surgery under spinal anesthesia.

Procedure: Adductor Canal Block (ACB) Only

Adductor Canal Block + Biceps Femoris Short Head Block (ACB+BiFeS)

ACTIVE COMPARATOR

Participants will undergo both adductor canal block and biceps femoris short head block at the end of surgery under spinal anesthesia.

Procedure: biceps femoris short head block + Adductor Canal Block (ACB)

Interventions

Ultrasound-guided injection of 10 mL 0.25% bupivacaine into the adductor canal targeting the femoral artery region, providing motor-sparing analgesia to the medial/anterior knee.

Adductor Canal Block (ACB)

Combination of adductor canal block (10 mL 0.25% bupivacaine) and biceps femoris short head block with 25 mL 0.25% bupivacaine, deposited at the interfascial plane between BiFeS muscle and lateral femoral cortex to extend analgesia to the posterolateral knee.

Adductor Canal Block + Biceps Femoris Short Head Block (ACB+BiFeS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • ASA physical status I-III
  • Scheduled for elective knee arthroscopy under spinal anesthesia
  • Ability to provide written informed consent

You may not qualify if:

  • Coagulopathy or bleeding diathesis
  • Current use of anticoagulant therapy
  • Known allergy or contraindication to local anesthetics used in the study
  • History of diabetes mellitus with neuropathy or other neuropathic disorders
  • Contraindications to regional anesthesia techniques
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Istanbul, küçükçekmece, 34303, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Single Person

Intervention Hierarchy (Ancestors)

Marital StatusFamily CharacteristicsDemographyPopulation CharacteristicsSocioeconomic Factors

Study Officials

  • Engin ihsan Turan, Specialist

    Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Engin ihsan Turan, principal investigator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will be blinded to group allocation. Outcome assessors recording pain scores, opioid consumption, and side effects will be blinded to the intervention. The anesthesiologists performing the blocks cannot be blinded due to the nature of the procedures.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomized in a 1:1 ratio to receive either an adductor canal block (ACB) or a combined adductor canal plus biceps femoris short head (ACB+BiFeS) block. Both interventions will be performed under ultrasound guidance at the end of surgery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 21, 2025

Study Start

November 20, 2025

Primary Completion

March 10, 2026

Study Completion

March 30, 2026

Last Updated

January 20, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations